von Deimling A - Search Results

1

Addressing diffuse glioma as a systemic brain disease with single-cell analysis.

Sahm F, Capper D, Jeibmann A, Habel A, Paulus W, Troost D, von Deimling A. Sahm F, et al. Among authors: von deimling a. Arch Neurol. 2012 Apr;69(4):523-6. doi: 10.1001/archneurol.2011.2910. Epub 2011 Dec 12. Arch Neurol. 2012. PMID: 22158715

2

Molecular genetic analysis as a tool for evaluating stereotactic biopsies of glioma specimens.

Müller MB, Schmidt MC, Schmidt O, Hayashi Y, Rollbrocker B, Waha A, Fimmers R, Volk B, Warnke P, Ostertag CB, Wiestler OD, von Deimling A. Müller MB, et al. Among authors: von deimling a. J Neuropathol Exp Neurol. 1999 Jan;58(1):40-5. doi: 10.1097/00005072-199901000-00005. J Neuropathol Exp Neurol. 1999. PMID: 10068312 Clinical Trial.

3

No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma.

Mueller W, Eum JH, Lass U, Paulus W, Sarkar C, Bruck W, von Deimling A. Mueller W, et al. Among authors: von deimling a. Neuropathol Appl Neurobiol. 2004 Jun;30(3):304-7. doi: 10.1046/j.0305-1846.2004.00538.x. Neuropathol Appl Neurobiol. 2004. PMID: 15175083

4

Brain slice invasion model reveals genes differentially regulated in glioma invasion.

Holtkamp N, Afanasieva A, Elstner A, van Landeghem FK, Könneker M, Kuhn SA, Kettenmann H, von Deimling A. Holtkamp N, et al. Among authors: von deimling a. Biochem Biophys Res Commun. 2005 Nov 4;336(4):1227-33. doi: 10.1016/j.bbrc.2005.08.253. Biochem Biophys Res Commun. 2005. PMID: 16171788

5

NF2 mutations in secretory and other rare variants of meningiomas.

Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A. Hartmann C, et al. Among authors: von deimling a. Brain Pathol. 2006 Jan;16(1):15-9. doi: 10.1111/j.1750-3639.2006.tb00557.x. Brain Pathol. 2006. PMID: 16612978 Free PMC article.

6

Chromosomal imbalances and NF2 mutational analysis in a series of 10 spinal nerve sheath myxomas.

Rickert CH, Schwering EM, Siebers J, Hartmann C, von Deimling A, Paulus W. Rickert CH, et al. Among authors: von deimling a. Histopathology. 2007 Jan;50(2):252-7. doi: 10.1111/j.1365-2559.2007.02579.x. Histopathology. 2007. PMID: 17222254

7

The evolution of our understanding on glioma.

Martin-Villalba A, Okuducu AF, von Deimling A. Martin-Villalba A, et al. Among authors: von deimling a. Brain Pathol. 2008 Jul;18(3):455-63. doi: 10.1111/j.1750-3639.2008.00136.x. Epub 2008 Mar 26. Brain Pathol. 2008. PMID: 18371180 Free PMC article. Review.

8

Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.

Siegelin MD, Reuss DE, Habel A, Rami A, von Deimling A. Siegelin MD, et al. Among authors: von deimling a. Neuro Oncol. 2009 Apr;11(2):122-31. doi: 10.1215/15228517-2008-085. Epub 2008 Oct 29. Neuro Oncol. 2009. PMID: 18971417 Free PMC article.

9

Analysis of the IDH1 codon 132 mutation in brain tumors.

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. Balss J, et al. Among authors: von deimling a. Acta Neuropathol. 2008 Dec;116(6):597-602. doi: 10.1007/s00401-008-0455-2. Epub 2008 Nov 5. Acta Neuropathol. 2008. PMID: 18985363

10

The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin.

Siegelin MD, Reuss DE, Habel A, Herold-Mende C, von Deimling A. Siegelin MD, et al. Among authors: von deimling a. Mol Cancer Ther. 2008 Nov;7(11):3566-74. doi: 10.1158/1535-7163.MCT-08-0236. Mol Cancer Ther. 2008. PMID: 19001439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

818 results

Search Page